<DOC>
	<DOCNO>NCT01724801</DOCNO>
	<brief_summary>EGFR-TKI good patient EGFR-mutant non-small cell lung cancer.We design clinical trail confirm efficacy Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ( EGFR-TKI ) ( ICOTINIB ) good whole brain irradiation patient EGFR-mutant non-small cell lung cancer .</brief_summary>
	<brief_title>Icotinib Whole Brain Irradiation EGFR-mutant Lung Cancer</brief_title>
	<detailed_description>available</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Patient confirm stage IV NSCLC EGFR activate mutation brain metastasis pathologic histology cytology . Patient brain metastasis show MRI CT scan . Brain metastases lesion 3.The diameter among lesion 1 centimeter . Males female age ≥18 year , &lt; 75 year . Eastern Cooperative Oncology Group ( ECOG ) performance status 01 . Life expectancy ≥12 week . The therapy surgery , chemotherapy , radiotherapy patient ever receive 2 week ago.The patient recover treatment . Males female contraceptive period trial 8 week last administration icotinib . Able comply require protocol followup procedure , able receive oral medication . Written inform consent provide . Patient receive irradiation brain . Patient meningeal metastasis confirm MRI cytology test cerebrospinal fluid . Patient receive treatment Phenytoin , carbamazepine , rifampicin , phenobarbital , St. John 's Wort . Patient receive EGFR Tyrosine Kinase Inhibitor EGFR monoclonal antibody . Interstitial pneumonia.Pericardial effusion , pleural effusion uncontrolled . Any unstable systemic disease ( include active infection , uncontrolled hypertension , unstable angina , congestive heart failure , myocardial infarction within previous year , serious cardiac arrhythmia require medication , hepatic , renal , metabolic disease ) . Any significant ophthalmologic abnormality , especially severe dry eye syndrome , keratoconjunctivitis sicca , Sjogren syndrome , severe exposure keratitis disorder likely increase risk corneal epithelial lesion . Lack physical integrity upper gastrointestinal tract , malabsorption syndrome , inability take oral medication , active peptic ulcer disease . Female subject pregnant breastfeeding . Adequate hematological function : Absolute neutrophil count ( ANC ) ≥1.5 x 109/L , Platelet count ≥100 x 109/L . Adequate renal function : Serum creatinine ≤ 1.5 x ULN , ≥ 50 ml/min . Adequate liver function : Total bilirubin £ 1.5 x upper limit normal ( ULN ) Alanine Aminotransferase ( ALT ) Aspartate Aminotransferase ( AST ) &lt; 2.5 x ULN absence liver metastasis , &lt; 5 x ULN case liver metastasis . The symptom increase intracranial pressure uncontrolled dehydration cortisone treatment . Patient need increase irradiation dose routine irradiation ( 30GY/10f/2w ) Patient treat extra cranial lesion first . Patient assess investigator unable unwilling comply requirement protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>EGFR mutant</keyword>
</DOC>